

Company Profile
GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK.
Ms. Erum Shakir Rahim | CEO |
Mr.Dmytro Oliinyk | Chairman |
Ms. Mehar-e-daraksha Ameer | Company Secretary |
CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi
Yousuf Adil, Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Nov 2, 2020 | Transmission of Quarterly Report for the Period Ended September 30, 2020 | View PDF |
Oct 28, 2020 | Financial Results for the Quarter ended September 30, 2020 | View PDF |
Aug 31, 2020 | Transmission of Quarterly Report for the Period Ended 2020-06-30 | View PDF |
Aug 24, 2020 | Financial Results for the Quarter ended June 30, 2020 | View PDF |
May 28, 2020 | Transmission of Quarterly Report for the Period Ended 2020-03-31 | View PDF |
May 15, 2020 | Financial Results for the Quarter ended March 31, 2020 | View PDF |
Apr 29, 2020 | Transmission of Annual Report for the Year Ended 2019-12-31 | View PDF |
Apr 16, 2020 | GRANT OF EXTENSION FOR FILLING OF FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2020 (Q-1) | View PDF |
Mar 11, 2020 | financial Results for the Year Ended December 31, 2019 | View PDF |
Oct 30, 2019 | Transmission of Quarterly Report for the Period Ended September 30, 2019 | View PDF |
Date | Title | Document |
---|---|---|
Jan 8, 2021 | Board Meeting Other than Financial Results | View PDF |
Jan 8, 2021 | Board Meeting Other than Financial Results | View PDF |
Oct 21, 2020 | Board of Directors Meeting | View PDF |
Aug 17, 2020 | Board of Directors Meeting | View PDF |
May 8, 2020 | Board of Directors Meeting | View PDF |
Apr 29, 2020 | Notice of Annual General Meeting | View PDF |
Apr 27, 2020 | Notice of the Annual General Meeting prior to its publication in the newspapers | View PDF |
Mar 11, 2020 | Board Meeting - Number of Directors | View PDF |
Mar 4, 2020 | Board of Directors Meeting GSK Pakistan Limited | View PDF |
Feb 19, 2020 | Emergent Board Meeting | View PDF |
Date | Title | Document |
---|---|---|
Jan 1, 2021 | Change of the Company Secretary | View PDF |
Jan 1, 2021 | CHANGE OF THE COMPANY SECRETARY | View PDF |
Dec 1, 2020 | Corporate Briefing Session | View PDF |
Nov 24, 2020 | Change in Particular of Auditors | View PDF |
Nov 5, 2020 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Oct 29, 2020 | GLAXO | GlaxoSmithKline Pakistan Limited - Transmission of Nine Months Accounts September 30, 2020 | |
Oct 29, 2020 | Material Information | View PDF |
Jun 15, 2020 | PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND | View PDF |
Jun 12, 2020 | PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND | View PDF |
May 21, 2020 | CERTIFIED TRUE COPY OF RESOLUTION | View PDF |
Financials
All numbers in thousands (000's) except EPS
2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|
Sales | 36,581,749 | 34,006,840 | 32,773,770 | 27,563,533 |
Profit after Taxation | 3,041,123 | 3,257,951 | 2,981,023 | 2,762,185 |
EPS | 9.55 | 10.23 | 9.36 | 8.68 |
Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | |
---|---|---|---|---|
Sales | 10,812,709 | 7,738,393 | 8,033,916 | 8,171,440 |
Profit after Taxation | 1,126,141 | 817,784 | 425,564 | 923,761 |
EPS | 3.54 | 2.57 | 1.34 | 2.90 |

Ratios
2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|
Gross Profit Margin (%) | 21.08 | 24.74 | 26.48 | 27.08 |
Net Profit Margin (%) | 8.31 | 9.58 | 9.10 | 10.02 |
EPS Growth (%) | (6.65) | 9.29 | 7.83 | 4.58 |
PEG | (2.53) | 1.19 | 2.29 | 5.87 |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
March 11, 2020 5:58 PM | 31/12/2019(YR) | 60%(F) (D) | 15/05/2020 - 21/05/2020 |
March 4, 2019 4:53 PM | 31/12/2018(YR) | 70%(F) (D) | 18/04/2019 - 24/04/2019 |
February 27, 2018 3:59 PM | 31/12/2017(YR) | 40% (D) | 18/04/2018 - 24/04/2018 |
October 26, 2017 5:47 PM | 30/09/2017(IIIQ) | 30% (D) | 10/11/2017 - 17/11/2017 |
March 8, 2017 4:03 PM | 31/12/2016(YR) | 60% (D) | 18/04/2017 - 24/04/2017 |
March 30, 2016 3:13 PM | 31/12/2015(YR) | 40% (D) | 20/04/2016 - 27/04/2016 |
February 25, 2015 3:51 PM | 31/12/2014(YR) | 50% (D) | 16/04/2015 - 23/04/2015 |
February 7, 2014 3:24 PM | 31/12/2013(YR) | 35% (D) - 10% (B) | 21/04/2014 - 28/04/2014 |
February 7, 2014 3:24 PM | 31/12/2013(YR) | 35% (D) - 10% (B) | 21/04/2014 - 28/04/2014 |
February 18, 2013 2:37 PM | 31/12/2012(YR) | 40% (F) (D) - 10% (B) | 12/04/2013 - 18/04/2013 |